Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer

Head and Neck

Volumn 31, Issue 2, 2009, Pages 244-250

  Martin, Richard C W ^a   Fulham, Michael ^a   Shannon, Kerwin F ^a   Hughes, Ceri ^a   Gao, Kan ^a   Milross, Chris ^a   Tin, Mo Mo ^a   Jackson, Michael ^a   Clifford, Anthony ^a   Boyer, Michael J ^a   O'Brien, Christopher J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cancer; Chemoradiotherapy; Head; Mucosal SCC; Neck; PET

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM STAGING; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59449083291     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20962     Document Type: Article

References (41)

1. Taylor SG IV, Murthy AK, Vannetzel JM, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994;12:385-395.
2. Adelstein DJ, Saxton JP, Lavertu P, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997;19:567-575.
3. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-2086.
4. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-98.
5. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324: 1685-1690.
6. Brizel DM, Escalamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastaic, squamous cell carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol 2006;24:2612-2617.
7. Gusack GS, Hudgins PA. Imaging modalities in recurrent head and neck tumours. Laryngoscope 1991;10:119-124.
8. Velazquez RA, McGuff HS, McGuff S, Sycamore D, Miller FR. The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell cancer after chemoradiotherapy. Arch Otollaryngol Head Neck Surg 2004;130:74-77.
9. Giron J, Chisin R, Paul JL, et al. Multimodality imaging of cervical adenopathies. Eur J Radiol 1996;21:159-166.
10. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 1992;158:961-969.
11. Anzai Y, Brunberg JA, Lufkin RB. Imaging of nodal me- tastases in the head and neck. J Magn Reson Imaging 1997;7:774-783.
12. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255- 1260.
13. Ware RE, Matthews JP, Hicks RJ, et al. Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality following definitive treatment for squamous cell carcinoma of the head and neck. Head Neck 2004;26:1008-1017.
14. Kubota K, Yokoyama J, Yamaguchi K, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004;31:590-595.
15. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-1379.
16. Pellitteri PK, Ferlito A, Rinaldo A, et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck 2005;28:166-175.
17. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791-798.
18. Peters LJ, Weber RS, Morrison WH, Byers RM, Garden AS, Goepfert H. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 1996;18:552-559.
19. Goguen LA, Marshall RP, Tishler RB, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2006;132:526-531.
20. Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy. Analysis of wound complications. Arch Otolaryngol Head Neck Surg 1995;121:162-165.
21. Lavertu P, Bonafede JP, Adelstein DJ, et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401-406.
22. Davidson BJ, Newkirk KA, Harter KW, Picken CA, Cullen KJ, Sessions RB. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 1999;125:401-405.
23. SPSS Inc. Chicago, version 11.5, 2002.
24. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205-216.
25. Goin JE, Hermann GA. The clinical efficacy of diagnostic imaging evaluation studies. Problems, paradigms and prescriptions. Invest Radiol 1985;26:507-511.
26. Zanation AM, Sutton BS, Couch ME, Weissler MC, Shockley WW, Shores CG. Use, accuracy, and implications for patient management of [18F]-2- fluorodeoxyglucose- positron emission/computerized tomography for head and neck tumours. Laryngoscope 2005;115:1186-1190.
27. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005;27:175-181.
28. Wong DT, Schoder SG, Patel M, et al. Diagnostic and prognostic value of [18f]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-4208.
29. Yao M, Smith RB, Graham MM, et al. The role of FDG pet in management of neck metastases from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2005;63:991-999.
30. Gandhi D, Falen S, McCartney W, et al. Value of 2-[18F]-fluorodeoxy-D- glucose imaging with dual-head gamma camera in coincidence mode: comparison with computed tomography? Magnetic resonance imaging in patients with suspected recurrent head and neck cancers. J Comput Assist Tomogr 2005;29:513-519.
31. Ryan WR, Fee WE, Le QT, Pinto HA. Positron-emission tomography for the surveillance of head and neck cancer. Laryngoscope 2005;115:645-650.
32. Zimmer LA, Snyderman C, Fukui MB, et al. The use of combined PET/CT for localizing recurrent head and neck cancer: the Pittsburgh experience. Ear Nose Throat J 2005;84:104-110.
33. Nam SY, Lee SW, Im KC, et al. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET. Oral Oncol 2005;41:390-395.
34. Branstetter BF, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235:580-586.
35. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiotherapy? Int J Radiat Oncol Biol Phys 2004;58:694-697.
36. Kutler DI, Patel SG, Shah JP. The role of neck dissection following definitive chemoradiation. Oncology 2004;18:993-998.
37. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in the setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418-1423.
38. Wanebo H, Chougule P, Ready N, et al. Surgical resection is necessary to maximise tumour control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 2001;8:644-650.
39. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000; 26:447-455.
40. Agiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-455.
41. Schwartz DL, Rajendran J, Yueh B, et al. Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg 2003;129:1173-1178.